CrossrefInfokarte
Correction to “Targeting T Cell–Mediated Inflammation: Clinical Benefits of Lifitegrast in Improving Symptoms and Signs of Dry Eye Disease”
Journal of Ophthalmology · 2026-01 · 2026 (1)
DOI: 10.1155/joph/9857150 ↗Abstract
Kein Abstract verfügbar.
EUVIMED